Study of Zola-cel (BMS-986353), in Participants With Autoimmune Cytopenia (Breakfree-AiCE)

Clinical trial NCT07603557 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07603557
Sponsor: Juno Therapeutics, Inc., a Bristol-Myers Squibb Company
Status: NOT_YET_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Chronic Immune Thrombocytopenia Autoimmune Hemolytic Anemia

Start date: 2026-08-31
Primary completion: 2030-05-06
Enrollment: 52

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.